Back to search

Article

Serum Biomarker Profile Orchestrating the Seroconversion Status of Patients With Autoimmune Diseases Upon Planned Primary 17DD Yellow Fever Vaccination

2020-12-29

Abstract excerpt

The present study aimed to investigate whether the serum biomarkers of immune response orchestrate the seroconversion status in patients with autoimmune diseases (AID) upon planned primary 17DD-YF vaccination. For this purpose a total of 161 individuals were enrolled in a prospective study, including patients with rheumatoid arthritis (RA=38), spondyloarthritis (SpA=51), systemic lupus erythematosus (SLE=21) and S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30a83ec8-e234-570d-9eaa-4364e03c7a8d
DOI
10.21203/rs.3.rs-128333/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum Biomarker Profile Orchestrating the Seroconversion Status of Patients With Autoimmune Diseases Upon Planned Primary 17DD Yellow Fever VaccinationDOI 10.21203/rs.3.rs-128333/v1
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsSemantic proximity
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionSemantic proximity
COVID-19 vaccines and autoimmune disorders: A scoping review protocolSemantic proximity
The Impact of COVID-19 Vaccination on Autoimmune Disorders: A Descriptive AnalysisSemantic proximity
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trialSemantic proximity
Persistent Autoimmune Activation and Proinflammatory State in Post-COVID SyndromeSemantic proximity
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differencesSemantic proximity
Impaired Immunogenicity to COVID-19 Vaccines in Autoimmune Systemic Diseases - High Prevalence of Non-Response in Different Patients’ SubgroupsSemantic proximity
Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE TrialSemantic proximity
Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccinationSemantic proximity
Longitudinal proteomic investigation of COVID-19 vaccinationSemantic proximity
Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccinationSemantic proximity
Select a neighboring publication to make it the new centre.